Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis — Stella

Home/Hyperphosphatemia Patients on Hemodialysis/A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

View on ClinicalTrials.gov

Recruiting

Back to Hyperphosphatemia Patients on Hemodialysis trials

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Japan

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

Key details

Phase

Large-scale testing

Sponsor

Taisho Pharmaceutical Co., Ltd.

Enrollment target

~300 participants

Started

December 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.